(2026). Liraglutide combined with dapagliflozin treatment improves myocardial disease and endothelial dysfunction in T2DM mice. Journal of Diabetes Investigation.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Liraglutide Combined with Dapagliflozin Treatment Improves Myocardial Disease and Endothelial Dysfunction in T2DM Mice."
Journal of Diabetes Investigation 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Liraglutide Combined with Dapagliflozin Treatment Improves Myocardial Disease and Endothelial Dysfunction in T2DM Mice."
Journal of Diabetes Investigation, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.